The South America Genetic Testing Market was valued at USD 1.064 billion in 2024 and is projected to reach USD 1.753 billion by 2035, expanding at a CAGR of 4.64% from 2025 to 2035. Technological advancements, increasing public awareness, expanding healthcare infrastructure, and rising demand for personalized medicine are supporting market development across the region.
The market includes single-gene tests, panel tests, whole exome sequencing, whole genome sequencing, and non-invasive prenatal testing. Panel tests currently represent the largest testing category, while whole exome sequencing is identified as an emerging and rapidly expanding segment as sequencing becomes more accessible and efficient.
Prenatal testing represents the dominant application segment, while newborn screening is identified as the fastest-growing application. Carrier testing, diagnostic testing, and predictive testing also contribute to the market as awareness of inherited conditions and the benefits of early genetic assessment increases.
Brazil accounts for a significant share of the regional market, supported by healthcare investment, biotechnology development, and demand for genetic testing in areas such as prenatal care and oncology. Mexico, Argentina, Chile, and Colombia are also contributing to regional development as genetic testing becomes increasingly integrated into healthcare systems.
Dive into related studies for a broader industry perspective:
Chronic Lower Back Pain Treatment Market Volume
Chronic Lower Back Pain Treatment Market Forecast
Chronic Lower Back Pain Treatment Market Outlook
